Asahi Kasei Corporate Venture Capital

Glycomine, Inc. is a biotech company based in San Carlos, California, focused on developing nanomedicines for rare genetic disorders, particularly those related to protein and lipid glycosylation. Founded in 2014, the company addresses the significant unmet medical needs of patients suffering from rare diseases, of which approximately 7,000 exist globally, with a majority lacking FDA-approved treatments. Glycomine specializes in creating replacement therapies that combine substrates, enzymes, and proteins with advanced bio-nano materials. These therapeutics are designed to facilitate the targeted delivery of treatment to clinically relevant organs, thereby enhancing the efficacy of care for conditions characterized by metabolic disorders and protein misfolding.

Swing Therapeutics is focused on developing innovative digital therapeutics aimed at improving the lives of individuals with chronic conditions. The company assembles a team of scientists, clinicians, and technologists who collaborate with leading researchers to create evidence-based treatments. These digital solutions are designed to empower patients, allowing them to manage their health more effectively and regain control over their illnesses. By providing transformative therapeutic options, Swing Therapeutics seeks to enhance the overall well-being of patients, enabling them to lead healthier and more fulfilling lives.

Koya Medical, Inc. is a healthcare company based in Oakland, California, founded in 2018. The company specializes in developing innovative wearable therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. Koya Medical's technology offers active compression therapy that enhances mobility and personalized care, addressing limitations commonly associated with traditional compression methods. Its sensor-based closed-loop system provides patient-specific patterned compression, enabling healthcare providers to effectively manage conditions like chronic edema and chronic venous insufficiency. Through its breakthrough treatments, Koya Medical seeks to transform the standard of care for individuals affected by these debilitating conditions.

Rege Nephro Co., Ltd. is a biotechnology company based in Kyoto, Japan, founded in 2019. It specializes in the research and development, production, and marketing of therapeutics for renal diseases, utilizing nephron progenitor cells and induced pluripotent stem cell (iPSC) technology from the Center for iPS Cell Research and Application at Kyoto University. The company focuses on developing innovative treatments and cell therapies for kidney, liver, and pancreas diseases, aiming to reduce the reliance on dialysis for patients with renal failure. Additionally, Rege Nephro produces kidney organoids that facilitate nephrotoxicity screening for drug discovery, enhancing applied research in the field of nephrology.

Aerobiotix is a privately held company focused on creating and producing proprietary environmental management devices designed for institutional healthcare, home health, and commercial applications. The company specializes in innovative technologies aimed at efficiently eliminating airborne viruses, bacteria, and spores, thereby optimizing indoor environments. By addressing critical health concerns related to air quality, Aerobiotix provides solutions that enhance safety and well-being in various settings.

Hazel Technologies, Inc. is a biotechnology company focused on reducing waste in the agricultural supply chain through innovative packaging solutions. Founded in 2015 and headquartered in Chicago, Illinois, with an additional facility in Salinas, California, the company designs and manufactures packaging inserts, such as sachets, that are placed in produce boxes at the time of harvest. These inserts utilize ethylene inhibitors to slow the aging process of fruits and vegetables, thereby extending their shelf life and reducing spoilage. Hazel Technologies also offers agricultural and horticultural consulting services to growers and shippers, helping them improve the efficiency of their operations. The effectiveness of their products is supported by research from independent academic institutions, and the company has received funding from the United States Department of Agriculture to further its mission of combating food waste and enhancing profitability within the fresh produce sector.

Firework is a technology company that specializes in video commerce solutions. It operates a platform designed for websites, apps, and stores, allowing businesses to stream videos directly on their sites. The platform offers features such as in-video shopping, lead generation, live streaming events, and video import/editing tools. These capabilities enable brands to engage with and convert their website visitors more effectively.

Shenzhen Dami He Xiaomi Cultural Broadcast Co., Ltd., known as Dami & Xiaomi, operates an online platform dedicated to supporting children with autism spectrum disorders. Established in 2014 and based in Shenzhen, China, the company offers a range of integrated services including rehabilitation, educational support, parent training, online courses, and science information. Dami & Xiaomi aims to address the needs of children with developmental disorders, focusing on effective strategies to help them manage autism and promote healthy growth. Through its comprehensive platform, it provides essential resources to empower parents and caregivers in their efforts to support their children's development.

Hazel Technologies, Inc. is a biotechnology company focused on reducing waste in the agricultural supply chain through innovative packaging solutions. Founded in 2015 and headquartered in Chicago, Illinois, with an additional facility in Salinas, California, the company designs and manufactures packaging inserts, such as sachets, that are placed in produce boxes at the time of harvest. These inserts utilize ethylene inhibitors to slow the aging process of fruits and vegetables, thereby extending their shelf life and reducing spoilage. Hazel Technologies also offers agricultural and horticultural consulting services to growers and shippers, helping them improve the efficiency of their operations. The effectiveness of their products is supported by research from independent academic institutions, and the company has received funding from the United States Department of Agriculture to further its mission of combating food waste and enhancing profitability within the fresh produce sector.

Feldan Therapeutics is a biopharmaceutical company focused on developing innovative therapies using its patented Feldan Shuttle technology. This platform facilitates rapid and secure intracellular delivery of therapeutics, expanding treatment possibilities by accessing previously unreachable cellular components. The company's current pipeline comprises clinical programs leveraging this unique technology to advance novel therapeutic applications.